Feeds:
Posts
Comments

Posts Tagged ‘pharmaceutical companies’

And if anyone thinks there is no connection between the big pharmaceutical companies and the cancer hospitals, read this research:

The most powerful drug magnates are sitting on the board of directors of Memorial Sloan-Kettering Cancer Center in New York City, and other major cancer hospitals and research centers. Is it no wonder that a woman and her son are running from chemotherapy in search of alternative medicine that will never ever receive any good publicity because the people at the top are also running Bristol-Myers, Pfizer, and Merck, the biggest drug producing companies.

What research has shown is that many of the top directors (what they call “overseers”) at Memorial Sloan-Kettering are also top directors at drug companies. For instance, Richard Furlow, who is the President of Bristol-Myers Squibb and Director of the Pharmaceutical Manufacturers’ Association, is a top official of Memorial Sloan-Kettering. Richard Gelb, who is the Chairman of the Board of Bristol-Myers Squibb, is a Vice Chairman of Memorial Sloan-Kettering. James D. Robinson, a Director of Bristol-Myers Squibb, is another Vice President of Memorial Sloan-Kettering. The President of Memorial Sloan-Kettering Cancer Center, Paul Marx, is a Director of Pfizer [pharmaceuticals]. And others [officials
of Memorial Sloan-Kettering] are Directors of Bio-Technology General, Life Technologies, Merck, and so forth.

And so what happens, in effect, is that you have a . . . closed circle of people who are, on the one hand, directors of the world’s largest cancer center; on the other hand, they are either officers or directors of the very companies that are producing the drugs which are used and advocated by these centers. . . . There are many, many ways that the drug industry influences the direction of cancer research, and of AIDS research. You have to look at it from an economic point of view . . . isn’t it all about money??

They want to treat you, not cure you. This has been their philosophy all this while. It is no different in Malaysia.

More info (still do not see the connection?):

Percentage of cancer patients whose lives are predictably saved by chemotherapy – 3%

Conclusive evidence (majority of cancers) that chemotherapy has any positive influcence on survival or quality of life – none.

Percentage of oncologists in a study who said if they had cancer they would not participate in chemotherapy trials due to its “ineffectiveness and its unacceptable toxicity” – 75%

Percentage of people with cancer in the U.S. who receive chemotherapy – 75%.

Company that accounts for nearly half of the chemotherapy sales in the world – Bristol-Meyers Squibb.

* Chairman of the board of Bristol-Meyers – Richard L. Gelb.
* Mr. Gelb’s other job: vice chairman, board of overseers, board of managers, Memorial Sloan-Kettering Cancer Center, World’s largest private cancer treatment and research center.

Chairman, Memorial Sloan-Kettering’s board of overseers, board of managers – John S. Reed.

* Reed’s other job – director, Philip Morris (tobacco company).

Director, Ivax, Inc., a prominent chemotherapy company – Samuel Broder.

* Broder’s other job (until 1995) – executive director, National Cancer Institute.

Read Full Post »